Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus.

International journal of cancer - 22 Aug 1997

Chong J M, Fukayama M, Hayashi Y, Funata N, Takizawa T, Koike M, Muraoka M, Kikuchi-Yanoshita R, Miyaki M, Mizuno S

Abstract excerpt

The significance of CD44 variants in gastric carcinoma has not been fully investigated in terms of the pathological features of the carcinoma, including its association with Epstein-Barr virus (EBV). In this study, a total of 104 primary gastric carcinoma tissues (EBV-associated gastric carcinomas, EBVaGC, and EBV-negative carcinomas) were evaluated by immunohistochemistry. When the immunoreactivity of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Genetic Variation

Share to Immunohistochemistry

Share to RNA, Viral

Share to Sex Characteristics

Source

Identifiers

PMID: 9291438
DOI: 10.1002/(sici)1097-0215(19970822)74:4<450::aid-ijc16>3.0.co;2-d

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus.PMID 9291438Read ↗

Expression of CD44 alternative splicing variants in primary and lymph node metastatic lesions of gynecological cancer.Semantic proximity Read ↗

Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C<sub>44</sub>Mab-94 against Gastric CarcinomasSemantic proximity Read ↗

Epstein-Barr virus-associated gastric carcinoma: a distinct carcinoma of gastric phenotype by claudin expression profiling.Semantic proximity Read ↗

Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C44Mab-5Semantic proximity Read ↗

Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma.Semantic proximity Read ↗

Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer CellsSemantic proximity Read ↗

Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma.Semantic proximity Read ↗

Differential expression of CD44 splice variants in malignant and benign pleural effusions.Semantic proximity Read ↗

Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.Semantic proximity Read ↗

The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.Semantic proximity Read ↗

Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C<sub>44</sub>Mab-3 for Multiple Applications against Pancreatic CarcinomasSemantic proximity Read ↗

The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.